Author:Li BW, Silva JR, Lu XC, Luo L, Wang YF, Xu LZ, Aierken A, Shynykul Z, Kamau PM, Luo AA, Yang J, Su DY, Yang F, Cui JM, Yang SL, Lai R.

Publication Name: Cellular and Molecular Life Sciences

Pub Year:2019

DOI:2019. doi: 10.1007/s00018-019-03339-3

IF: 7.014

Abstract:Ubiquitin modification plays significant roles in protein fate determination, signaling transduction, and cellular processes. Over the past 2 decades, the number of studies on ubiquitination has demonstrated explosive growth. E3 ubiquitin ligases are the key enzymes that determine the substrate specificity and are involved in cancer. Several recent studies shed light on the functions and mechanisms of HECTD3 E3 ubiquitin ligase. This review describes the progress in the recent studies of HECTD3 in cancer and other diseases. We propose that HECTD3 is a potential biomarker and a therapeutic target, and discuss the future directions for HECTD3 investigations.